Track topics on Twitter Track topics that are important to you
3275 Corporate View
United States of America
David Stamler has joined Australia’s Prana Biotechnology as chief medical officer and senior vice president,…
This week's roundup includes senior appointments by Prana Biotechnology, Octapharma, Silence Therapeutics and ABPI, in addition to board appointments by...
David Stamler, M.D., has joined Prana Biotechnology (ASX: PBT) (NASDAQ: PRAN) as Chief Medical Officer and Senior Vice President, Clinical Development, based in San Francisco. Pri...
Life Sciences Jobs ...
Scrip scans for early stage research – from bench to clinic – that could lead to novel treatments or changes...
Intended mainly to provide evidence of a safety advantage compared to existing SGLT2 inhibitors, meeting the net-benefit primary endpoint in...
SummaryPrana Biotechnology Ltd Prana Biotech is a pharmaceutical company that develops therapeutic drugs. The company is conducting research into Huntington disease, Alzheimer's disease, brain cancer,...
Prana Biotechnology was established to commercialise research into Alzheimer's disease and other major age-related neurodegenerative disorders. The Company was incorporated in 1997 and listed on the A...
Prana Biotechnology has developed a proprietary library of class-leading chemical compounds. This library is combined with a drug development program to explore novel therapeutics in multiple disease ...
We have published hundreds of Prana news stories on BioPortfolio along with dozens of Prana Clinical Trials and PubMed Articles about Prana for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Prana Companies in our database. You can also find out about relevant Prana Drugs and Medications on this site too.